With the increasing utilization of somatic gene testing and immunohistochemistry (IHC) for cancer patients suspected of LS, a subset of patients with microsatellite instability (MSI) or loss of MMR protein expression by IHC in the tumor tissue but without germline MMR pathogenic variants could be identified. Here, MRC1 is linked to cancer.